No intervention
Pre-clinicalCompleted 0 watching 0 views this week💤 Quiet
23
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Musculoskeletal Diseases
Conditions
Musculoskeletal Diseases
Trial Timeline
Aug 1, 2002 → May 1, 2010
NCT ID
NCT00210639About No intervention
No intervention is a pre-clinical stage product being developed by Johnson & Johnson for Musculoskeletal Diseases. The current trial status is completed. This product is registered under clinical trial identifier NCT00210639. Target conditions include Musculoskeletal Diseases.
Hype Score Breakdown
Clinical
5
Activity
2
Company
10
Novelty
2
Community
1
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00210977 | Pre-clinical | Withdrawn |
| NCT00211068 | Pre-clinical | Completed |
| NCT00210639 | Pre-clinical | Completed |
Competing Products
4 competing products in Musculoskeletal Diseases
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Eperisone hydrochloride and Diclofenac sodium + Eperisone hydrochloride | Eisai | Phase 3 | 77 |
| ACE-083 | Merck | Phase 1 | 33 |
| Lumiracoxib | Novartis | Approved | 85 |
| Nerve Growth Factor | Lundbeck | Pre-clinical | 20 |